Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn’s Disease: Results From the Phase 3 GRAVITI Study
Pharmacology, Toxicology and Pharmaceutical Science
4
5%
Biochemistry, Genetics and Molecular Biology
2
3%
Immunology and Microbiology
2
3%
Engineering
2
3%
Other
3
4%
Unknown
42
57%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 96. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2026.
All research outputs
#563,815
of 34,609,551 outputs
Outputs from Gastroenterology
#495
of 16,945 outputs
Outputs of similar age
#7,491
of 372,264 outputs
Outputs of similar age from Gastroenterology
#9
of 124 outputs
Altmetric has tracked 34,609,551 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,945 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 372,264 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 124 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.
